Filtered By: Topstories
News

8 minor Sputink V adverse events managed successfully; vaccinees sent home –DOH


The Department of Health recorded eight minor Sputnik V adverse events, Health Undersecretary Maria Rosario Vergeire said Saturday.

“Among those given with Sputnik V vaccine for these past days, mayroon tayong eight reported na adverse events. Lahat ito non-serious, or minor,” Vergeire said during the Laging Handa briefing.

(Among those given with Sputnik V vaccine for these past days, there were eight reported adverse events. All were non-serious or minor.)

Among the reported adverse events were body ache, injection site pain, rashes, backache, headache, nausea, and an increase in blood pressure.

“All of these were managed at lahat ay nakauwi pagtapos,” she said.

(All of these were managed and everyone was able to go home.)

The DOH also reported that there had been no mishandling or improper Sputnik V storage incidents.

The 15,000 trial-order doses of the Russia-made Sputnik V COVID-19 vaccine were given to five local government units in Metro Manila.

The cities of Makati, Taguig, Muntinlupa, Manila, and Parañaque were given 3,000 doses each.

Last Saturday, the plane carrying the trial-order doses of Russia's Gamaleya Research Institute vaccine landed in Manila. Its arrival was delayed twice due to logistical concerns.

The DOH earlier said it would push through with the inoculations of the Russian vaccine despite efficacy concerns reported by Brazil.

In March, the Philippine FDA has approved the EUA (emergency use authorization) of the Russian-made vaccine.

The FDA said Sputnik V had a 91% efficacy rate— DVM, GMA News